Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 3 November 2006:
Vol. 314. no. 5800, p. 721
DOI: 10.1126/science.314.5800.721a
Table of Contents | Next

This Week in Science

Figure 1 In Tübingen, Germany, on 3 November 1906, Alois Alzheimer described the first documented case of Alzheimer's disease, a neurodegenerative disorder that impairs memory, cognition, and behavior (see the cover). Goedert and Spillantini (p. 777) review what is known about the molecular pathology of the disease, which is defined by the presence within the brain of amyloid-beta-rich plaques and tau-containing neurofibrillary tangles. Roberson and Mucke (p. 781) review the prospects for therapy to help delay or prevent pathological processes within the brains of afflicted individuals, in order to prolong patients' cognitive abilities, and maintain for as long as possible their quality of life.

CREDIT: UNIVERSITY CLINIC OF TÜBINGEN




To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)